BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10975587)

  • 1. Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with an alpha1-adrenergic antagonist.
    Rimoldi O; Spyrou N; Foale R; Hackett DR; Gregorini L; Camici PG
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):310-5. PubMed ID: 10975587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergically mediated coronary vasoconstriction in patients with syndrome X.
    Camici PG; Marraccini P; Gistri R; Salvadori PA; Sorace O; L'Abbate A
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):221-6. PubMed ID: 7918134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X.
    Rosen SD; Lorenzoni R; Kaski JC; Foale RA; Camici PG
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):554-60. PubMed ID: 10511131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
    Gregorini L; Fajadet J; Robert G; Cassagneau B; Bernis M; Marco J
    Circulation; 1994 Aug; 90(2):895-907. PubMed ID: 8044961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed recovery of coronary resistive vessel function after coronary angioplasty.
    Uren NG; Crake T; Lefroy DC; de Silva R; Davies GJ; Maseri A
    J Am Coll Cardiol; 1993 Mar; 21(3):612-21. PubMed ID: 8436742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb vasoconstriction after successful angioplasty of the left anterior descending coronary artery.
    Indolfi C; Piscione F; Ceravolo R; Maione A; Focaccio A; Rao MA; Esposito G; Condorelli M; Chiariello M
    Circulation; 1995 Oct; 92(8):2109-12. PubMed ID: 7554189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium dependent and independent responses in coronary artery disease measured at angioplasty.
    Holdright DR; Clarke D; Poole-Wilson PA; Fox K; Collins P
    Br Heart J; 1993 Jul; 70(1):35-42. PubMed ID: 7518687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha 1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans.
    Lorenzoni R; Rosen SD; Camici PG
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1302-6. PubMed ID: 8897921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: relation to stenosis and myocardial viability.
    Claeys MJ; Vrints CJ; Bosmans J; Krug B; Blockx PP; Snoeck JP
    J Am Coll Cardiol; 1996 Dec; 28(7):1712-9. PubMed ID: 8962556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis.
    Fischell TA; Derby G; Tse TM; Stadius ML
    Circulation; 1988 Dec; 78(6):1323-34. PubMed ID: 2973376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study.
    Jagathesan R; Rosen SD; Foale RA; Camici PG; Picano E
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):110-6. PubMed ID: 17031264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of doxazosin on functional alterations of isolated coronary arteries from cholesterol-fed rabbits.
    Simonsen U; Prieto D; Nyborg NC; Mulvany MJ
    J Pharm Pharmacol; 1996 Jun; 48(6):607-14. PubMed ID: 8832495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of regional coronary flow reserve assessed by adenosine thallium-201 scintigraphy early and six months after successful percutaneous transluminal coronary angioplasty or stent implantation.
    Versaci F; Tomai F; Nudi F; Gaspardone A; De Fazio A; Ciavolella M; Crea F; Mango L; Chiariello L; Gioffrè PA
    Am J Cardiol; 1996 Nov; 78(10):1097-102. PubMed ID: 8914870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents.
    Gregorini L; Marco J; Palombo C; Kozàkovà M; Anguissola GB; Cassagneau B; Bernies M; Distante A; Marco I; Fajadet J; Zanchetti A
    J Am Coll Cardiol; 1998 Apr; 31(5):992-1001. PubMed ID: 9561999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of coronary flow reserve using digital angiography before and after successful percutaneous transluminal coronary angioplasty.
    Hodgson JM; Riley RS; Most AS; Williams DO
    Am J Cardiol; 1987 Jul; 60(1):61-5. PubMed ID: 2955694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction.
    Stewart RE; Miller DD; Bowers TR; McCullough PA; Ponto RA; Grines CL; O'Neill WW; Juni JE; Safian RD
    J Nucl Med; 1997 May; 38(5):770-7. PubMed ID: 9170444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of coronary arterial renarrowing by continuous 3-day infusion of tissue plasminogen activator after successful percutaneous transluminal coronary angioplasty: a randomized, double-blind, placebo-controlled study.
    Kanamasa K; Ogawa I; Hayashi T; Nakabayashi T; Otani N; Ishikawa K
    Angiology; 2000 May; 51(5):367-75. PubMed ID: 10826853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.